Cite
Pensato U, Baraldi C, Favoni V, et al. Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache. Neurol Sci. 2021;doi: 10.1007/s10072-021-05426-5.
Pensato, U., Baraldi, C., Favoni, V., Cainazzo, M. M., Torelli, P., Querzani, P., Pascazio, A., Mascarella, D., Matteo, E., Quintana, S., Asioli, G. M., Cortelli, P., Pierangeli, G., Guerzoni, S., & Cevoli, S. (2021). Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, . https://doi.org/10.1007/s10072-021-05426-5
Pensato, Umberto, et al. "Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. (2021). doi: https://doi.org/10.1007/s10072-021-05426-5
Pensato U, Baraldi C, Favoni V, Cainazzo MM, Torelli P, Querzani P, Pascazio A, Mascarella D, Matteo E, Quintana S, Asioli GM, Cortelli P, Pierangeli G, Guerzoni S, Cevoli S. Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache. Neurol Sci. 2021 Jul 05; doi: 10.1007/s10072-021-05426-5. Epub 2021 Jul 05. PMID: 34224026.
Copy
Download .nbib